Monday 9 December 2013

New test to detect cancer in the making

New test to detect cancer in the making

A new diagnostic test should soon be capable of cancers that are resistant to address. Traditional forms of chemotherapy to new test to detect cancer in the making. Is This Program a Kyle Leon Scam?

The Flemish Institute for Biotechnology (VIB) and KU Leuven collaborate with Biotech Company to develop cancers that are resistant to traditional forms of chemotherapy. A new diagnostic test that can be read in a press release of the VIB and KU Leuven

Movements

The VIB research group of Dither Hambrecht’s has a new set of landmarks in the DNA identified that indicate whether a cancer MMR-deficient. Or a cancer or non-MMR-deficient, it is important information for the treatment. Healthy cells have indeed a mismatch repair' mechanism (MMR), which allows new mutations of cells undone.

Cancer cells produced by an accumulation of mutations the risk of cancer increases when cells so that mutations cannot stop, because the MMR mechanism is disabled. This result in MMR-deficient cancers, that are resistant to the traditional form of chemotherapie.MMR deficiency is also a good indication for possible heritability of the cancer.

Adenoma cinema

The VIB research now has a new set of markers for Microsatellite Instability, which occurs in MMR deficiency identified. Introduction to Kyle Leon

Such markers may be used for the detection of cancers. a biotech company for molecular diagnostics that diagnostic platforms and corresponding tests develops, will use the results to develop.

No comments:

Post a Comment